RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Deltex Medical Group Stock

Deltex Medical Group P/S 2024

Deltex Medical Group P/S

7.98

Ticker

DEMG.L

ISIN

GB0059337583

WKN

927020

As of Nov 17, 2024, Deltex Medical Group's P/S ratio stood at 7.98, a 136.09% change from the 3.38 P/S ratio recorded in the previous year.

The Deltex Medical Group P/S history

Deltex Medical Group Aktienanalyse

What does Deltex Medical Group do?

Deltex Medical Group PLC is a leading provider of anesthesia, intensive care, and emergency medicine monitoring products. The company develops and produces products for patient monitoring during anesthesia and cardiovascular system monitoring. Additionally, Delta Medical offers training for healthcare professionals. The company specializes in developing and producing products that enable real-time monitoring of blood flow and fluid volume. These products are primarily designed for use in anesthesia, intensive care, and emergency medicine. The technology allows medical professionals to improve both patient care and process efficiency. Deltex Medical operates in the anesthesia, intensive care, and emergency medicine industries. Each industry has specific patient monitoring requirements, and Deltex Medical offers specialized products for each area. For example, anesthesia products focus on monitoring fluid volume and blood flow during anesthesia. Intensive care products continuously measure fluid volume and blood flow in patients with severe illnesses or injuries. Deltex Medical's emergency medicine products enable rapid patient monitoring in acute medical situations. Some of Deltex Medical's products include the CardioQ-ODM+ and the TrueVue system for monitoring cardiovascular functions and vital signs. The CardioQ-ODM+ is a non-invasive system designed for anesthesia, intensive care, and emergency medicine patients. The TrueVue system is an invasive system used during surgeries and in intensive care to monitor blood flow and fluid volume in real-time. Both systems provide real-time data that allows for quick and accurate adjustments to patient care. Deltex Medical also offers training for healthcare professionals to ensure optimal use of the systems. The training is aimed at anesthesiologists, intensivists, and emergency medicine physicians, covering both theory and practical application of the systems. The training can be conducted online or in-person. In 2011, Deltex Medical received a significant award for its work in anesthesia monitoring. The Technology Industry Award praised the company for its continuous innovation and mission to improve clinical practice. In summary, Deltex Medical Group PLC is a leading provider of anesthesia, intensive care, and emergency medicine monitoring products. The company has a wide product portfolio that includes both invasive and non-invasive systems. Additionally, Deltex Medical offers training to ensure optimal use of the systems by healthcare professionals. With its technical expertise and commitment to clinical practice, Deltex Medical Group PLC has become a valuable partner in the healthcare industry. Deltex Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Deltex Medical Group's P/S Ratio

Deltex Medical Group's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Deltex Medical Group's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Deltex Medical Group's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Deltex Medical Group’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Deltex Medical Group stock

What is the price-to-earnings ratio of Deltex Medical Group?

The price-earnings ratio of Deltex Medical Group is currently 7.98.

How has the price-earnings ratio of Deltex Medical Group changed compared to last year?

The price-to-earnings ratio of Deltex Medical Group has increased by 136.09% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Deltex Medical Group high compared to other companies?

Yes, the price-to-earnings ratio of Deltex Medical Group is high compared to other companies.

How does an increase in the price-earnings ratio of Deltex Medical Group affect the company?

An increase in the price-earnings ratio of Deltex Medical Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Deltex Medical Group affect the company?

A decrease in the price-earnings ratio of Deltex Medical Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Deltex Medical Group?

Some factors that influence the price-earnings ratio of Deltex Medical Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Deltex Medical Group pay?

Over the past 12 months, Deltex Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Deltex Medical Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Deltex Medical Group?

The current dividend yield of Deltex Medical Group is .

When does Deltex Medical Group pay dividends?

Deltex Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deltex Medical Group?

Deltex Medical Group paid dividends every year for the past 0 years.

What is the dividend of Deltex Medical Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deltex Medical Group located?

Deltex Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Deltex Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deltex Medical Group from 11/17/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did Deltex Medical Group pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of Deltex Medical Group in the year 2023?

In the year 2023, Deltex Medical Group distributed 0 GBP as dividends.

In which currency does Deltex Medical Group pay out the dividend?

The dividends of Deltex Medical Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Deltex Medical Group

Our stock analysis for Deltex Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deltex Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.